Literature DB >> 31053518

Regulatory T cells and M2-polarized tumour-associated macrophages are associated with the oncogenesis and progression of oral squamous cell carcinoma.

A Kouketsu1, I Sato2, M Oikawa3, Y Shimizu3, H Saito4, K Tashiro4, Y Yamashita5, T Takahashi4, H Kumamoto3.   

Abstract

Regulatory T cells (Tregs) and tumour-associated macrophages (TAMs) contribute to the tumour microenvironment by inhibiting anti-tumour immune responses. This study was performed to investigate the roles of Tregs and TAMs in oral squamous cell carcinoma (OSCC) and oral epithelial precursor lesions (OEPL). The expression of Treg markers CD25 and FoxP3 and TAM markers CD163 and CD204 was investigated in 82 OSCC and 45 OEPL specimens, and their associations with clinicopathological parameters were analyzed. Correlations were found among CD25, FoxP3, CD163, and CD204 levels (P <  0.001), and these targets were up-regulated in OSCC compared to OEPL (P <  0.001). In OSCC, infiltration of Tregs and/or M2 TAMs was associated with sex and clinicopathological features, such as tumour size, nodal metastasis, tissue differentiation, stromal reaction, invasive behaviour, and invasive depth. In OEPL, CD25, FoxP3, CD163, and CD204 immunoreactivities were significantly associated with sex, postoperative recurrence, and cancerization to OSCC. This study is novel in showing that the infiltration of Tregs and M2 TAMs is significantly associated with the progression of premalignant lesions to OSCC. This suggests that these cells represent prognostic biomarkers for premalignant lesion progression and that immunotherapeutic approaches to control Treg/M2 TAM numbers could protect against progression to malignancy.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  oral cancer; oral epithelial precursor lesions; regulatory T cell; squamous cell carcinoma; tumour-associated macrophage

Mesh:

Year:  2019        PMID: 31053518     DOI: 10.1016/j.ijom.2019.04.004

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  23 in total

Review 1.  Mechanism of tumour microenvironment in the progression and development of oral cancer.

Authors:  Mohd Mughees; Anindita Sengupta; Sapna Khowal; Saima Wajid
Journal:  Mol Biol Rep       Date:  2021-01-25       Impact factor: 2.316

Review 2.  The 'Danse Macabre'-Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes.

Authors:  Sara Hadjigol; Bansari A Shah; Neil M O'Brien-Simpson
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

Review 3.  Precision and Immunoprevention Strategies for Tobacco-Related Head and Neck Cancer Chemoprevention.

Authors:  Sara M Centuori; Carlos Caulin; Julie E Bauman
Journal:  Curr Treat Options Oncol       Date:  2021-05-15

4.  Early changes in the immune microenvironment of oral potentially malignant disorders reveal an unexpected association of M2 macrophages with oral cancer free survival.

Authors:  Jebrane Bouaoud; Jean-Philippe Foy; Antonin Tortereau; Lucas Michon; Vincent Lavergne; Nicolas Gadot; Sandrine Boyault; Julie Valantin; Geneviève De Souza; Philippe Zrounba; Chloé Bertolus; Nathalie Bendriss-Vermare; Pierre Saintigny
Journal:  Oncoimmunology       Date:  2021-06-27       Impact factor: 8.110

5.  Immune evasion in HPV- head and neck precancer-cancer transition is driven by an aneuploid switch involving chromosome 9p loss.

Authors:  William N William; Xin Zhao; Joy J Bianchi; Heather Y Lin; Pan Cheng; J Jack Lee; Hannah Carter; Ludmil B Alexandrov; Jim P Abraham; David B Spetzler; Steven M Dubinett; Don W Cleveland; Webster Cavenee; Teresa Davoli; Scott M Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 12.779

Review 6.  Immunotherapy for HPV associated cancer.

Authors:  Ian H Frazer; Janin Chandra
Journal:  Papillomavirus Res       Date:  2019-07-13

7.  Evaluation of density of tumor-associated macrophages using CD163 in histological grades of oral squamous cell carcinoma, an immunohistochemical study.

Authors:  Nayana Chaudhari; Nilima Prakash; G L Pradeep; Aarti Mahajan; Snehal Lunawat; Vaibhavi Salunkhe
Journal:  J Oral Maxillofac Pathol       Date:  2021-01-09

Review 8.  Treg: A Promising Immunotherapeutic Target in Oral Diseases.

Authors:  Yujing Zhang; Jihua Guo; Rong Jia
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

9.  Age-related changes in T lymphocytes of patients with head and neck squamous cell carcinoma.

Authors:  S S Jeske; P J Schuler; J Doescher; M N Theodoraki; S Laban; C Brunner; T K Hoffmann; M C Wigand
Journal:  Immun Ageing       Date:  2020-02-12       Impact factor: 6.400

Review 10.  Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma.

Authors:  Areeg Elmusrati; Justin Wang; Cun-Yu Wang
Journal:  Int J Oral Sci       Date:  2021-08-02       Impact factor: 6.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.